News | November 10, 2024
Fortis Healthcare Q2 FY25 PAT up 5% at Rs. 193 Cr
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Hospital business revenues increase 13.9% to Rs. 1,655 crore
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
The company uses iPS cells to develop treatments for diseases relating to the kidney
ISB 2001 demonstrated a favorable safety and tolerability profile, and an overall response rate (ORR) of 75% in r/r MM
US Generics grew 5% to Rs. 467 Crores for the quarter
Revenue from Operations during Q2 FY25 was Rs. 3,077 crore as compared to Rs. 2,708 crore in Q2 FY24.
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Raises 2024 revenue guidance to a range of US$ 61 to US$ 64 billion
Revenue share from the North America increased to 79% in Q2 FY25 as compared to 67% in Q2 FY24
Subscribe To Our Newsletter & Stay Updated
